| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |